Latest total current liabilities for VAXX: $18M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Vaxxinity (VAXX) currently reports a total current liabilities of $18M as of December 2023. That compares with $31M in the prior-year period — down 43.1% year over year. Use the charts on this page to explore Vaxxinity's total current liabilities history and peer comparisons.
Vaxxinity's total current liabilities decreased from $31M to $18M — a 43.1% year-over-year decrease (period ending December 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Vaxxinity reported $18M in total current liabilities as of December 2023. That compares with $31M in the prior-year period — down 43.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total current liabilities of $18M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Vaxxinity, and consider following VAXX for alerts when major investors trade the stock.